Back to search results

Virtual Reality for Chronic Pain in Younger Patients

This study is looking at whether using virtual reality (VR) games can help younger patients aged 7 to 21 manage chronic pain in their head, neck, or upper body. You would participate in 6 weekly sessions, each lasting about an hour. During these sessions, you would do physical therapy exercises and play VR games designed to help with movement. Researchers will measure your pain intensity using a Numeric Rating Scale and your ability to do daily activities using the Upper Extremity Functional Scale each week for 6 weeks to see if the interventions are helpful. This study is currently unclear on its recruitment status and plans to enroll 20 participants.

Study design
This is an interventional study with 20 planned participants. It is not specified if it is randomized or blinded.
What's involved
You would attend 6 once-weekly, hour-long sessions. Each session involves physical therapy exercises, virtual reality gaming, and completing questionnaires.
Compensation
Not stated in the trial record.
Follow-up
Your pain and disability will be assessed weekly from enrollment to the end of treatment at 6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07630350

Using Virtual Reality Applications for Younger Patients With Chronic Pain

Enrolling by Invitation
NAAges 7–21InterventionalTreatment
Elizabeth Pickle
~20 participants
Updated 2026-07-31 on ClinicalTrials.gov
What's tested:Virtual reality gamingPhysical therapy exercises

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain Intensity Based on Numeric Rating Scale
Measured over Weekly assessment from enrollment to the end of treatment at 6 weeks
+1 more outcome measured

Conditions

Chronic Pain Management

Explore related trials

Chronic Joint Pain of the Upper LimbChronic neck painChronic pain of right upper limbChronic Scapular PainComplex regional pain syndrome of upper limbMigrainePain Amplification SyndromeShoulder Pain

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Elizabeth A Pickle, MD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh Medical Center Children's Hospital of Pittsburgh

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients 7-21 years of age
Patients who have been evaluated in the pediatric chronic pain clinic during the enrollment period or last 12 months
Patients who have a diagnosis of migraine, chronic neck pain, chronic shoulder or scapular pain, chronic pain of the upper limb, complex regional pain syndrome of the upper limb, amplified musculoskeletal pain syndrome affecting the upper limb, chronic joint pain affecting the upper limb

Exclusion

Patients less than 7 years or greater than 21 years of age
Patients who have not been evaluated in the pediatric chronic pain clinic during the enrollment period or last 12 months.
Patients with primary complaints of lower back pain, hip pain, knee pain, ankle pain, or abdominal pain.
Patients with factors limit their ability to safely tolerate wearing and operating the Meta Oculus 2 virtual reality goggles, including but not limited to claustrophobia, anxiety, vestibulo-ocular dysfunction, visual impairments, significant sitting balance impairments.

What this trial measures

  • Pain Intensity Based on Numeric Rating ScaleWeekly assessment from enrollment to the end of treatment at 6 weeks

    Ranges from 0 (no pain) to 10 (worst pain imaginable)

  • Disability Classification based on the Upper Extremity Functional ScaleWeekly assessment from enrollment to the end of treatment at 6 weeks

    20-item questionnaire asking participant to rate difficulty of specified activities using the upper extremity with possible answers ranging from 1 (extreme difficulty or unable to perform activity) to 4 (no difficulty).